Here, we test the role of two other possible factors: 1) a reduced peripheral vasoconstriction (which may contribute because PD includes a generalized sympathetic denervation); and 2) an inadequate plasma volume (which may explain why plasma volume expansion can manage orthostatic hypotension in PD). We included 11 PD patients with orthostatic hypotension (PD ϩ OH), 14 PD patients without orthostatic hypotension (PD Ϫ OH), and 15 agematched healthy controls. Leg blood flow was examined using duplex ultrasound during 60°head-up tilt. Leg vascular resistance was calculated as the arterial-venous pressure gradient divided by blood flow. In a subset of 9 PD ϩ OH, 9 PD Ϫ OH, and 8 controls, plasma volume was determined by indicator dilution method with radiolabeled albumin ( 125 I-HSA). The basal leg vascular resistance was significantly lower in PD ϩ OH (0.7 Ϯ 0.3 mmHg·ml Ϫ1 ·min) compared with PD Ϫ OH (1.3 Ϯ 0.6 mmHg·ml Ϫ1 ·min, P Ͻ 0.01) and controls (1.3 Ϯ 0.5 mmHg·ml Ϫ1 ·min, P Ͻ 0.01). Leg vascular resistance increased significantly during 60°head-up tilt with no significant difference between the groups. Plasma volume was significantly larger in PD ϩ OH (3,869 Ϯ 265 ml) compared with PD Ϫ OH (3,123 Ϯ 377 ml, P Ͻ 0.01) and controls (3,204 Ϯ 537 ml, P Ͻ 0.01). These results indicate that PD ϩ OH have a lower basal leg vascular resistance in combination with a larger plasma volume compared with PD Ϫ OH and controls. Despite the increase in leg vascular resistance during 60°h ead-up tilt, PD ϩ OH are unable to maintain their blood pressure.
SYMPTOMATIC AND ASYMPTOMATIC orthostatic hypotension (OH) is present in 30 -60% of patients with Parkinson's disease (PD) (15) and negatively correlated with quality of life (32) . In elderly, OH is associated with cardiovascular morbidity and mortality (31, 33) . The pathophysiology of OH in PD remains incompletely understood. Until now, the focus has been primarily on impairment of central mediated vasoconstrictor mechanisms. PD patients have a reduced baroreflex cardiovagal function, denervation of the heart, low norepinephrine levels, and no increment in norepinephrine levels during orthostatic challenges (14, 39) . However, baroreflex failure and cardiac sympathetic denervation contribute to but cannot fully explain OH in PD (14, 16) .
During orthostatic challenges peripheral vasoconstriction contributes to maintain blood pressure via a central mediated vasoconstrictor mechanism, i.e., baroreflex, and local vasoconstrictor mechanisms, such as the venoarteriolar axon reflex (21) and the myogenic response (11) . Since in PD a generalized rather than a central sympathetic denervation is present (40) , central and local mediated peripheral vasoconstriction might be affected and, thereby, might play an important role in the pathophysiology of OH in PD.
Furthermore, a lower plasma volume may be another contributing factor to OH in PD. This assumption is based on the important role of the sympathetic nervous system in volume homeostasis via renal innervation and the renin-angiotensin system (6) . In addition, a relation is present between baroreflex-mediated vascular control (26) , time to presyncope (10) , and blood pressure during orthostatic challenges in autonomic failure (46) . In addition, plasma volume expansion is considered an effective therapy in PD patients with OH (38) . However, data on possible baseline differences in plasma volume in PD are lacking.
The aim of this study was to assess peripheral vascular responses in PD patients with and without OH, as well as in controls. For this purpose, we measured leg vascular resistance at baseline and during 60°head-up tilt. In addition, we aimed to measure plasma volume in these three groups. We hypothesized that baseline leg vascular resistance, the leg vascular resistance increase during 60°head-up tilt, and plasma volume are lower in PD patients with OH compared with PD patients without OH and controls.
METHODS
Subjects. Twenty-five PD patients and 15 age-and sex-matched controls participated. All patients were diagnosed by an experienced neurologist (R. A. J. Esselink or B. R. Bloem) and fulfilled the criteria of the UK Brain Bank for idiopathic PD (13) . Disease severity [Hoehn and Yahr stages (22) ] and severity of motor symptoms [Unified Parkinson Disease Rating Scale (UPDRS) part III (3)] were assessed. PD patients were assigned to two groups according to the presence of OH. OH was defined as a decrease of Ն20 mmHg in systolic or Ն10 mmHg in diastolic blood pressure during the first 3 min of active standing or during a passive 60°head-up tilt (1) . Eleven PD patients fulfilled the consensus criteria of OH (PD ϩ OH), leaving 14 PD patients without OH (PD Ϫ OH) ( Table 1 ). The two patient groups showed no significant differences for various important baseline variables, including disease duration, disease severity, and levodopa equivalent dose (Table 1) (27, 30) . None of the controls fulfilled the OH criteria. Exclusion criteria were smoking, cardiovascular disease, diabetes, and hypertension. None of the subjects used medication known to relevantly interfere with vascular function, except for Parkinson medication, which was continued during the study. In a randomly selected subgroup, of the original study group, we determined plasma volume (Table 3) .
The study was performed in accordance with the Declaration of Helsinki and approved by the medical ethical committee of our institution. All subjects gave written informed consent.
Experimental procedures and protocol. Before the head-up tilt experiment and the plasma volume measurement, all subjects refrained from caffeine-containing beverages, vitamin C supplements, and alcohol for Ͼ12 h and from heavy physical activity for Ͼ24 h, and had been fasting for Ͼ2 h. All head-up tilt experiments and plasma volume measurements were performed in the morning in a quiet, temperature-controlled room (23 Ϯ 1°C).
Subjects laid down on a manually driven tilt-table with footboard. The subjects supported their body weight during the 60°head-up tilt by standing on the left leg, allowing the right leg to be relaxed for blood flow measurements. To minimize possible muscle tensing during head-up tilt, the thigh of the weight-bearing leg was supported by a strap to keep it extended and by supporting straps around the waist and chest. A venous catheter was placed in an antecubital vein of the right arm. After a supine resting period of at least 30 min, subjects were tilted manually, within 5 s, to a passive 60°head-up tilt position for a 10-min period. In the subgroup plasma volume was determined on a separate occasion within 7-21 days after the head-up tilt testing.
Measurements. Blood pressure was measured continuously using a noninvasive blood pressure device (Nexfin, BMEYE, The Netherlands). A finger cuff was attached to the middle phalanx of the left third finger to measure finger arterial blood pressure, which accurately reflects intra-arterial blood pressure changes (23) . A built-in heart reference system was in operation to correct for hydrostatic influences. Mean arterial blood pressure (MAP) was derived beat to beat and heart rate was the inverse of the interbeat interval. Stroke volume and systemic vascular resistance were determined by a three-element model of arterial input impedance using Modelflow (20) . Cardiac output was calculated as stroke volume times heart rate.
Upper leg blood flow during the last minute of supine rest and 60°h ead-up tilt was measured using duplex ultrasound. Mean red blood cell velocity (V mean) and diameter of the right superficial femoral artery, ϳ2 cm distal of the bifurcation, were measured with a duplex ultrasound device (ARTLAB system, Pie Medical, The Netherlands; WAKI, Atys Medical, France). V mean was calculated as the average of 20 ultrasound waveforms and diameter was calculated as the average of 6 consecutive mean diameters. Leg blood flow was calculated as (·r 2 ·Vmean)·60, where r ϭ 1/2·diameter of the superficial femoral artery.
Calf venous pooling was determined by measuring the calf volume change using plethysmography. Mercury-in-Silastic strain gauges were placed around the thickest part of the right calf and connected to a plethysmograph (Hokanson). To avoid any direct contact with the tilt-table, the calf was supported by small cushions. The difference in calf volume between 60°head-up tilt and supine was determined and expressed as percentage increase.
Venous blood samples during the first minute of supine rest and last minute of 60°head-up tilt were taken to determine plasma norepinephrine levels as described previously (47) .
Plasma volume was determined by indicator dilution method using radiolabeled albumin ( 125 I-HSA) (2). A venous catheter was placed in an antecubital of the right arm, followed by a supine resting period of at least 30 min. A known quantity of 125 I-HSA was injected via the venous catheter and, subsequently, venous blood samples from the contralateral antecubital vein were drawn after 10, 20, 30, and 40 min. Subjects remained supine throughout the entire plasma volume determination.
Data analysis. Leg vascular resistance was calculated as the arterial-venous pressure gradient divided by leg blood flow. Supine venous pressure was set at 9 mmHg and during 60°head-up tilt the arterial-venous pressure gradient was replaced by MAP, since hydrostatic pressure makes an identical contribution to leg venous as well as leg arterial pressure (17) .
Plasma volume was determined by dividing the total injected radioactivity by the virtual volume-specific radioactivity at time 0, which corresponds with the injection of 125 I-HSA (2). Measured plasma volume was expressed according to the calculated lean body mass [men: 1.10·weight Ϫ 128·(weight 2 /100·height 2 ), women: 1.07·weight Ϫ 148·(weight 2 /100·height 2 ) (24)]. A predicted plasma volume was calculated based on sex, body weight, and height (36) .
Statistical analysis. Data are presented as means Ϯ SD, unless otherwise stated. The level of statistical significance was set at ␣ ϭ 0.05. Unpaired t-tests were used to assess differences in predicted and measured plasma volume within the groups. ANOVAs were used to assess differences in subject characteristics, baseline supine values, 60°head-up tilt values, and plasma volume. Repeated-measures ANOVAs were used to assess the effect of 60°head-up tilt. Bonferroni's correction was used to correct for multiple comparisons. Post hoc t-tests were performed when the ANOVA reported a significant effect. 
RESULTS
In the PD ϩ OH group, baseline leg blood flow was significantly higher and leg vascular resistance was significantly lower compared with PD Ϫ OH (P Ͻ 0.01 for both parameters) and controls (P Ͻ 0.01 for both parameters) ( Table 2 ). The diameter of the superficial femoral artery in PD ϩ OH (P Ͻ 0.01) and controls (P ϭ 0.02) was significantly larger compared with PD Ϫ OH ( Table 2 ). Heart rate in PD Ϫ OH was significantly higher compared with PD ϩ OH (P ϭ 0.02) and controls (P Ͻ 0.01) ( Table 2 ). Stroke volume in PD ϩ OH was significantly (P ϭ 0.05) larger compared with controls (Table 2 ). No differences in baseline systolic and diastolic blood pressure, MAP, cardiac output, systemic vascular resistance, or norepinephrine levels were observed (Table 2) .
During 60°head-up tilt, systolic blood pressure and MAP significantly decreased in PD ϩ OH (Table 2) . Heart rate significantly increased and stroke volume significantly decreased in all groups with a similar magnitude ( Table 2) . Cardiac output and systemic vascular resistance did not change during 60°head-up tilt. Leg blood flow decreased significantly in all groups during 60°head-up tilt, with a higher decrease in PD ϩ OH compared with PD Ϫ OH and controls (Table 2) . (Table 2 ). Leg vascular resistance during 60°head-up tilt in PD ϩ OH was significantly lower compared with PD Ϫ OH (P Ͻ 0.01) and controls (P ϭ 0.01) ( Table 2 ). The superficial femoral artery diameter significantly decreased during 60°head-up tilt in PD ϩ OH and controls but not in PD Ϫ OH (Table 2) . Norepinephrine levels significantly increased during 60°head-up tilt in controls and PD Ϫ OH but not in PD ϩ OH (Table 2) .
No difference in baseline calf circumference was present between the groups (controls: 37 Ϯ 2, PD Ϫ OH 35 Ϯ 2 and PD ϩ OH 37 Ϯ 2 cm). Calf volume increased during 60°head-up tilt in all groups, with a significant smaller calf volume increase in PD ϩ OH compared with controls (Table 2) .
Plasma volume was significantly larger in PD ϩ OH compared with PD Ϫ OH (P Ͻ 0.01) and controls (P Ͻ 0.01) ( Table 3 ). In PD ϩ OH the measured plasma volume was significantly larger (P Ͻ 0.01) compared with predicted (Table  3) . Plasma volume corrected for lean body mass was signifi- cantly larger in PD ϩ OH (62.0 Ϯ 3.1 ml/kg) compared with PD Ϫ OH (54.1 Ϯ 5.6 ml/kg, P Ͻ 0.01) and controls (53.8 Ϯ 7.6, P Ͻ 0.01) (Fig. 1) .
DISCUSSION
The major findings of this study are that PD ϩ OH have a lower basal leg vascular resistance, in combination with a larger plasma volume, compared with both PD Ϫ OH and controls. The leg vascular resistance increase during 60°h ead-up tilt was not different between the three groups, resulting in a lower leg vascular resistance during 60°head-up tilt in PD ϩ OH compared with PD Ϫ OH and controls. The lower leg vascular resistance in PD ϩ OH might, therefore, play a role in the pathophysiology of OH in PD.
The present study is the first to demonstrate a lower basal leg vascular resistance in PD ϩ OH compared with PD Ϫ OH and controls. This novel finding is in agreement with our hypothesis and in line with the accepted pathophysiology of OH in PD. Since PD is associated with a generalized rather than a central sympathetic denervation (40) , an attenuated sympathetic activity may explain the lower leg vascular resistance in PD ϩ OH. Muscle sympathetic nerve activity (MSNA) in PD decreases with age, disease duration, and severity (41) . This might indicate that generalized sympathetic denervation is more pronounced in PD ϩ OH than in PD Ϫ OH. However, denervation of sympathetic fibers to the heart has been shown to exist not only in PD ϩ OH but also in PD Ϫ OH and even in early PD (14, 19) . A second explanation could be the lower norepinephrine levels in PD ϩ OH. We did not find a significant difference in basal norepinephrine levels between the groups, in contrast to other studies (14, 15, 39, 40) , although norepinephrine in our study tended to be lower in PD ϩ OH. The lack of a norepinephrine difference could be due to larger standard deviations of norepinephrine levels in our PD patients who are treated with levodopa (16) . Although norepinephrine is a potent vasoconstrictor, vascular tone is regulated by a combination of several vasoconstrictors and dilators. The effect of lower norepinephrine levels in PD ϩ OH on vascular tone and leg vascular resistance is unknown. A decrease in ␣-adrenoceptors or in their sensitivity to norepinephrine could be a third explanation, especially in combination with lower norepinephrine levels. However, in PD ϩ OH there is evidence for ␣-adrenoceptor supersensitivity caused by sympathetic denervation (35) . The explanation for the lower basal leg vascular resistance in PD ϩ OH is, therefore, most likely sympathetic denervation of the legs.
In contrast to our hypothesis leg vascular resistance increased during 60°head-up tilt in PD ϩ OH, and to a similar extent as in PD Ϫ OH and controls. During orthostatic challenges an immediate drop in blood pressure is sensed by baroreceptors. This increases heart rate, cardiac contractility, and peripheral vascular resistance via an increase in sympathetic outflow and a decrease in vagal-nerve activity (12, 42) . One previous study measured local vascular resistance of the anterior tibial muscle and subcutaneous tissue of the calf in PD ϩ OH during 45°head-up tilt using the 133-xenon washout method, but did not find a significant increase (5). The smaller experimental vascular bed, lower tilt angle, and small number of subjects could explain the difference with our study. The leg vascular resistance increase during 60°head-up tilt in PD ϩ OH in our study is unlikely to be explained by spared sympathetic fibers since norepinephrine levels in PD ϩ OH did not increase during 60°head-up tilt, in concordance with previous studies (14, 39) . Local vasoconstrictor mechanisms might be involved in maintaining blood pressure during orthostatic challenges, i.e., the veno-arteriolar axon reflex (VAR) and the myogenic response. Preserved local vasoconstriction mechanisms have been previously demonstrated in a small number of PD ϩ OH and allocated to the VAR (5). The VAR is a local axon reflex triggered by an Ͼ25 mmHg increase in venous pressure, which results in constriction of the corresponding arteriole and assumed to be ␣-adrenergic mediated (21) . Since in PD ϩ OH there is no increase in norepinephrine levels, it is unlikely that the VAR contributes to the leg vascular resistance increase during 60°head-up tilt. More likely, the myogenic response is responsible for the observed leg vascular resistance increase in PD ϩ OH. The myogenic response is a smooth muscle vasoconstrictor response to increments in transmural pressure independent of the sympathetic nervous system (11) . The myogenic response is thought to play a major role during orthostatic challenges in autonomic failure (11, 18) . The myogenic response can, therefore, at least partly explain the leg vascular resistance increase in PD ϩ OH during 60°head-up tilt whether or not accompanied by a partly spared central mediated ␣-adrenergic vasoconstriction.
The increase in leg vascular resistance during 60°head-up tilt was not different between the groups. Since the basal leg vascular resistance was significantly lower, the leg vascular resistance during 60°head-up tilt was also lower in PD ϩ OH compared with PD Ϫ OH and controls. This means that the leg vasoconstriction during 60°head-up tilt in PD ϩ OH is insufficient to compensate for the lower basal leg vascular resistance. Furthermore, the leg vasoconstriction in PD ϩ OH is insufficient to counteract the decrease in blood pressure during 60°head-up tilt. The compensatory local vasoconstrictor mechanisms are unable to increase leg vascular resistance in PD ϩ OH during 60°head-up tilt to a satisfactory level that can prevent the development of OH. A lack of appropriate leg vasoconstriction seems, therefore, to play an important role in the pathophysiology of OH in PD, especially in combination with the lower basal leg vascular resistance in PD ϩ OH. A larger calf volume increase is associated with a larger decrease in venous return and, thereby, can contribute to OH (42) . In contrast, during 60°head-up tilt the calf volume increase was lower in PD ϩ OH compared with controls and tended to be lower compared with PD Ϫ OH. However, it might be that fluid filtration had already occurred during the morning before testing. This edema might serve as a kind of "water jacket" around the veins, preventing further fluid filtration during head-up tilt in autonomic failure (45) . Furthermore, venous pooling in other vascular beds, especially the splanchnic vascular bed, might still play a role in a decreased venous return in PD ϩ OH.
Besides central and local mediated vasoconstrictor mechanisms, an adequate plasma volume is essential for orthostatic tolerance (12) . To our best knowledge, this is the first study to demonstrate a larger plasma volume in PD ϩ OH compared with PD Ϫ OH and controls. The larger plasma volume in PD ϩ OH is in contrast to our hypothesis and to two previous studies in autonomic failure (7, 46) . The larger plasma volume in PD ϩ OH could be a compensation for the lower leg vascular resistance, supported by the correlation between leg vascular resistance and plasma volume. As a result of the lower leg vascular resistance, vascular capacity is increased and will result in a relative low plasma volume (29) , which could lead to a reduced renal arterial pressure. Consequently, renin will be released and more angiotensin II will be formed leading to aldosterone release, and thereby increasing plasma volume (8) . However, plasma renin concentration in PD seems to be lower than in controls (37) . Unfortunately, we do not know whether the renin-angiotensin-aldosterone system in PD ϩ OH is activated. Vasopressin or antidiuretic hormone is unlikely to play a role, since plasma levels in a small group of PD ϩ OH were comparable to controls (4) and vasopressin treatment had no effect (25) . A reduced red blood cell mass because of downregulation of erythropoiesis caused by renal denervation has been associated with a larger plasma volume in autonomic failure to normalize total blood volume (6, 7) . One study tested this association and demonstrated a nonsignificant marginal larger plasma volume in individuals with autonomic failure and a reduced red blood cell mass compared with controls (7) . In contrast, we demonstrated a significant larger plasma volume in PD ϩ OH compared with PD Ϫ OH and controls. Red blood cell mass and total blood volume in PD are unknown and was not determined in the present study. However, it seems unlikely that the large difference in plasma volume between PD ϩ OH and PD Ϫ OH and controls is entirely explained by a reduced red blood cell mass. The larger plasma volume in PD ϩ OH could be due to a higher sodium intake, since sympathetic denervation leads to a plasma volume regulation depending on sodium intake (6, 7, 46) . Sodium intake was not explicitly controlled in our subjects. However, controls, PD Ϫ OH, and PD ϩ OH had a regular sodium diet, and resting blood pressures were not different between the groups. A higher sodium intake in PD ϩ OH is, therefore, unlikely to explain the larger plasma volume but is not completely excluded. Another, more technical, explanation could be related to the plasma volume measurement. Considerable endothelial damage could cause leakage of 125 I-HSA into the extravascular space, which will cause an overestimation of plasma volume. In PD endothelial function and possible damage are unknown. However, the transcapillary exchange rate, a measure for the albumin loss into the extravascular space, was not different between the groups, indicating no difference in endothelial function. Despite the larger plasma volume, PD ϩ OH are not able to maintain their blood pressure in an upright position. Possibly, they still have a relative low plasma volume as a result of the lower basal leg vascular resistance (29) . We controlled for other causes of plasma volume increase (8, 9, 43) , e.g., none of the subjects had a high dietary salt intake, slept in a head-up tilt position, or used volume expanders, and there were no differences in physical activity between the groups.
Limitations. In our 60°head-up tilt protocol the subjects support their body weight on one leg, allowing the non-weightbearing leg to be relaxed for blood flow measurements. This protocol has been used before (18, 28) , but might increase muscle tensing in the weight-bearing leg (44) and, thereby, increase muscle sympathetic nerve activity (MSNA) by the exercise pressor reflex (34) . We have tried to minimize the muscle tensing during 60°head-up tilt by supporting the thigh of the weight-bearing leg by a strap to keep it extended and supporting straps around the waist and chest.
We measured plasma volume in a subgroup for ethical reasons. We randomly selected the subjects from the original study group to avoid bias. The results of the plasma volume determination are convincing, even in our relatively small sample size. We do not believe that a larger sample size would change our results.
Clinical Perspectives
Despite several published recommendations on the treatment of OH in PD, they are scarcely evidenced based (38) . Several nonpharmacological interventions have presumed efficacy by increasing venous return or plasma volume, i.e., elastic stockings, physical counter maneuvers, salt and fluid intake, sleeping in the head-up position, or increase physical activity (38) . Fludrocortisone (9␣-fluorohydrocortisone) and midodrine (␣-adrenoceptor agonist) are most commonly used in the pharmacological management of OH in PD (38) . The results of the present study, i.e., a lower leg vascular resistance with low norepinephrine levels and a larger plasma volume in PD ϩ OH, support the use of midodrine as a vasoconstrictive agent and, at the same time, question the use of fludrocortisone as a volume-expanding agent.
